Using Total Population Data To Describe The Characteristics Of Respiratory Infections In Order To Predict Future Epidemics And Recommend Vaccination Strategies For Western Australian Children
Funder
National Health and Medical Research Council
Funding Amount
$294,892.00
Summary
Respiratory infections are a major reason for children to go to hospital. I am an epidemiologist and I will be using previously collected and linked laboratory and hospital data from Western Australian children to better understand how these infections flow through the population over different seasons. I will then be able to predict future epidemics of respiratory infections and how different vaccine programs might have an impact in reducing how many children are affected by these infections.
Vaccination Timeliness In Aboriginal And Non-Aboriginal Infants: Risk Factors For Delayed Vaccination And Impact On Disease Burden—a Record Linkage Study
Funder
National Health and Medical Research Council
Funding Amount
$538,183.00
Summary
Vaccination has had a significant impact, but preventable infections continue to occur, perhaps due to delayed uptake of scheduled doses. For the first time, we will link vaccination and other health records to: provide accurate estimates of the impact of vaccination; identify reasons for delayed vaccination; and quantify the expected reduction in disease burden if vaccination timeliness was improved. The study will help determine who would benefit most from efforts to improve timeliness.
Links2HealthierBubs: Influenza And Pertussis Vaccine Effectiveness And Safety In Pregnancy
Funder
National Health and Medical Research Council
Funding Amount
$676,333.00
Summary
Vaccination during pregnancy can offer protection against severe respiratory disease for infants in the first six months of life. For this reason, influenza and pertussis vaccines are routinely recommended during each pregnancy. Unfortunately, little is known about the ‘real world’ effect of both vaccines. We plan to conduct the largest and most comprehensive study to date to evaluate all vaccines routinely recommended in pregnancy in Australia.
Group A Streptococcal Human Challenge Study: Accelerating Vaccine Development
Funder
National Health and Medical Research Council
Funding Amount
$2,018,741.00
Summary
Infection with group A streptococcus (GAS) is a major cause of morbidity and mortality worldwide, including in the Aboriginal population of Australia. Concerted efforts for vaccine development have been hampered by the absence of a suitable animal model. To address this critical knowledge gap we propose to develop a controlled human infection model of GAS infection. This model will provide a direct pathway for the future appraisal of novel GAS vaccines.
The Role Of Capsid Protein Nucleolar Localisation In Chikungunya Virus: Implications For Vaccine Development
Funder
National Health and Medical Research Council
Funding Amount
$520,520.00
Summary
Chikungunya virus (CHIKV) is a globally widespread mosquito-borne alphavirus capable of causing considerable human morbidity and mortality. With no CHIKV vaccine or antiviral available this proposal aims to develop a live attenuated CHIKV vaccine, rationally designed by investigating the host cell nucleolar trafficking of CHIKV capsid protein. This vaccine has the potential to provide cross-protection against additional arthritogenic alphaviruses endemic to Australia such as Ross River virus.
Combining Health, Laboratory And Immunisation Data Sources To Identify Opportunities For The Prevention Of Chest Infections In Young Aboriginal And Non-Aboriginal Children
Funder
National Health and Medical Research Council
Funding Amount
$428,469.00
Summary
Chest infections are one of the major reasons children are admitted to hospital, particularly in Aboriginal children. This project will determine whether current vaccines have reduced hospital visits and how many children are affected by multiple infections. It will also identify where better vaccination programs are needed. This will be done by bringing together and analysing a range of infection and hospital records to paint a true picture of the impact of chest infections in children.
Funding our future: perceptions of the value of financial planning advice. This project will examine how perceptions of the value of financial planning advice are formed over time. If this is understood then both government and the industry can develop better strategies to encourage those who can benefit from financial advice to recognise and gain value from the service.
Discovery Early Career Researcher Award - Grant ID: DE240100475
Funder
Australian Research Council
Funding Amount
$448,008.00
Summary
Exploring Business Approaches to the Modern Slavery - Climate Change Nexus. This project aims to generate awareness and knowledge about the modern slavery – climate change nexus. Businesses can be linked to modern slavery and climate change through their operations and supply chains, and play a major role in mitigating these critical issues. The project will: (1) reveal the extent to which businesses recognise and address modern slavery and climate change as related issues; (2) develop an eviden ....Exploring Business Approaches to the Modern Slavery - Climate Change Nexus. This project aims to generate awareness and knowledge about the modern slavery – climate change nexus. Businesses can be linked to modern slavery and climate change through their operations and supply chains, and play a major role in mitigating these critical issues. The project will: (1) reveal the extent to which businesses recognise and address modern slavery and climate change as related issues; (2) develop an evidence-base detailing what constitutes meaningful and holistic business approaches and disclosures; (3) assess how market-based mechanisms are used to incentivise action and hold businesses to account. The outcomes will advance business efforts and accountability in relation to these problems and benefit impacted communities.
Read moreRead less
Impact Of DTP Schedules On The Immunogenicity Of 2 Doses Of 13v-PCV Followed By An Early Booster
Funder
National Health and Medical Research Council
Funding Amount
$2,651,687.00
Summary
This project aims to come up with a vaccination schedule to make pneumococcal vaccines more effective and affordable for Fiji and other developing countries. We will evaluate schedules involving a 2 dose primary series in early infancy with a booster at 9 months of age. We will compare the immune responses to 3 different primary series and 2 booster options. The results of this project will be used to provide advice, at global and country levels, regarding introduction of pneumococcal vaccines.
Industrial Transformation Training Centres - Grant ID: IC210100008
Funder
Australian Research Council
Funding Amount
$4,282,859.00
Summary
ARC Training Centre for Behavioural Insights for Technology Adoption (BITA). Australia needs accelerated adoption of innovation technologies to improve outcomes in health, agriculture and cybersecurity. Despite technically viable solutions, innovations fail to be adopted due to behavioural barriers. Behavioural approaches can promote significant gains by bridging the barriers to technology adoption. The Centre for Behavioural Insights for Technology Adoption will boost national productivity by i ....ARC Training Centre for Behavioural Insights for Technology Adoption (BITA). Australia needs accelerated adoption of innovation technologies to improve outcomes in health, agriculture and cybersecurity. Despite technically viable solutions, innovations fail to be adopted due to behavioural barriers. Behavioural approaches can promote significant gains by bridging the barriers to technology adoption. The Centre for Behavioural Insights for Technology Adoption will boost national productivity by identifying, designing and evaluating solutions that address these barriers. By uniting industry and government with world-leading interdisciplinary researchers, the Centre will build transformative capability in people, data and solutions and support Australian organisations to achieve higher returns on technology investment.Read moreRead less